⚖UPC-Intel
🇪🇺 UPC

UPC_CFI_181/2025

Court
Düsseldorf Local Division
Type of action
infringement
Patent
A CELL MEDIATED IMMUNE RESPONSE ASSAY WITH ENHANCED SENSITIVITY
Language
en
Claimant / applicant
  • QIAGEN Sciences, LLC
Defendant / respondent
  • bioMérieux S.A.
  • bioMérieux Deutschland GmbH

Track this case

Get an email when a new order or decision is published in UPC_CFI_181/2025.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.